Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Catheter Precision (VTAK) Enterprise Value (2023 - 2026)

Catheter Precision has reported Enterprise Value over the past 9 years, most recently at -$503000.0 for Q4 2025.

  • Quarterly Enterprise Value rose 82.49% to -$503000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$503000.0 through Dec 2025, up 82.49% year-over-year, with the annual reading at -$503000.0 for FY2025, 82.49% up from the prior year.
  • Enterprise Value was -$503000.0 for Q4 2025 at Catheter Precision, up from -$1.4 million in the prior quarter.
  • Over five years, Enterprise Value peaked at -$16000.0 in Q2 2024 and troughed at -$20.6 million in Q3 2021.
  • The 5-year median for Enterprise Value is -$5.6 million (2023), against an average of -$8.3 million.
  • Year-over-year, Enterprise Value surged 99.78% in 2024 and then plummeted 6637.5% in 2025.
  • A 5-year view of Enterprise Value shows it stood at -$15.0 million in 2021, then dropped by 5.41% to -$15.9 million in 2022, then soared by 77.52% to -$3.6 million in 2023, then increased by 19.41% to -$2.9 million in 2024, then soared by 82.49% to -$503000.0 in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Enterprise Value are -$503000.0 (Q4 2025), -$1.4 million (Q3 2025), and -$1.1 million (Q2 2025).